
Gymnemic acids in Gymnema sylvestre activate FOXO1-mediated gluconeogenesis through G6PC and PCK1 upregulation while enhancing glycogen synthesis via GSK3β inhibition, providing glucose-based energy production to compensate for impaired fatty acid β-oxidation in MCADD patients
